T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EQC
1826
DELISTED
Equity Commonwealth
EQC
| $761K | ﹤0.01% |
29,650
| – | – |
|
|
TCF
1827
DELISTED
TCF Financial Corporation Common Stock
TCF
| $759K | ﹤0.01% |
22,961
+3,700
| +19% | +$117K |
|
1828
American Homes 4 Rent
AMH
$12.3B
| $754K | ﹤0.01% |
47,000
+17,100
| +57% | +$287K |
|
1829
Horace Mann Educators
HMN
$2.1B
| $753K | ﹤0.01% |
20,710
| – | – |
|
|
MDR
1830
DELISTED
McDermott International
MDR
| $747K | ﹤0.01% |
46,650
-22,233
| -32% | -$347K |
|
|
AHL
1831
DELISTED
ASPEN Insurance Holding Limited
AHL
| $747K | ﹤0.01% |
15,600
+1,600
| +11% | +$75.9K |
|
1832
Universal Display
OLED
$4.17B
| $735K | ﹤0.01% |
14,200
+1,600
| +13% | +$80.7K |
|
1833
Viasat
VSAT
$11.9B
| $735K | ﹤0.01% |
12,200
| – | – |
|
|
MW
1834
DELISTED
THE MENS WAREHOUSE INC
MW
| $734K | ﹤0.01% |
11,450
| – | – |
|
1835
WPP
WPP
$5.8B
| $733K | ﹤0.01% |
6,500
| – | – |
|
1836
Rambus
RMBS
$11B
| $732K | ﹤0.01% |
50,500
| – | – |
|
1837
Leidos
LDOS
$17.6B
| $731K | ﹤0.01% |
18,100
+2,000
| +12% | +$84.1K |
|
|
FOE
1838
DELISTED
Ferro Corporation
FOE
| $731K | ﹤0.01% |
43,560
| – | – |
|
1839
KB Home
KBH
$3.47B
| $729K | ﹤0.01% |
43,900
+13,000
| +42% | +$198K |
|
|
FSL
1840
DELISTED
FREESCALE SEMICONDUCTOR LTD
FSL
| $727K | ﹤0.01% |
18,200
| – | – |
|
|
SMLR
1841
DELISTED
Semler Scientific
SMLR
| $725K | ﹤0.01% |
219,377
+400
| +0.2% | +$1.41K |
|
1842
Dana Inc
DAN
$3.19B
| $720K | ﹤0.01% |
35,000
| – | – |
|
1843
Hancock Whitney
HWC
$6.37B
| $720K | ﹤0.01% |
22,560
-3,300
| -13% | -$100K |
|
1844
Magna International
MGA
$18.8B
| $719K | ﹤0.01% |
12,800
| – | – |
|
1845
Acco Brands
ACCO
$404M
| $717K | ﹤0.01% |
92,267
+26,500
| +40% | +$208K |
|
1846
DNOW Inc
DNOW
$2.99B
| $717K | ﹤0.01% |
36,021
+5,100
| +16% | +$117K |
|
1847
Interactive Brokers
IBKR
$41.8B
| $715K | ﹤0.01% |
68,800
-7,200
| -9% | -$65.3K |
|
1848
InterDigital
IDCC
$8.91B
| $715K | ﹤0.01% |
12,560
| – | – |
|
|
SYA
1849
DELISTED
SYMETRA FINANCIAL CORPORATION COMMON STOCK
SYA
| $715K | ﹤0.01% |
29,591
+318
| +1% | +$7.75K |
|
1850
Credit Acceptance
CACC
$5.99B
| $714K | ﹤0.01% |
2,900
+500
| +21% | +$111K |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.